# Ptbp1 Knockdown in Glial Cells Promotes Motor and Sensory Function Recovery After Peripheral Nerve Injury

**Authors:** Honghao Song, Lei Peng, Dashuang Chen, Xiaoyi Fan, Tong Hua, Ruifeng Ding, Mengqiu Deng, Qianbo Chen, Mei Yang, Hongbin Yuan

PMC · DOI: 10.1111/cns.70531 · 2025-07-23

## TL;DR

Reducing Ptbp1 in glial cells helps recover motor and sensory functions after nerve injury by converting astrocytes into neurons and boosting nerve regeneration.

## Contribution

This study reveals dual mechanisms of Ptbp1 knockdown in promoting recovery from peripheral nerve injury via astrocyte reprogramming and SGC signaling activation.

## Key findings

- Ptbp1 knockdown in spinal astrocytes converts them to motor neurons and polarizes them to a neuroprotective A2 phenotype.
- Ptbp1 depletion in DRG satellite glial cells activates the ntng2/NGL-2 pathway, enhancing sensory axon regeneration.
- Blocking ntng2 eliminates sensory regeneration, confirming its pathway dependency.

## Abstract

Background: Peripheral nerve injury (PNI) frequently causes persistent sensory and motor deficits with limited therapeutic options. While Ptbp1‐mediated astrocyte reprogramming shows promise in central nervous system repair, its role in PNI—particularly regarding spinal cord astrocytes and dorsal root ganglia (DRG) satellite glial cells (SGCs)—remains unexplored.Aims: This study aimed to determine whether Ptbp1 knockdown in glial cells enhances functional recovery after sciatic nerve injury (SNI) by dual mechanisms: (1) converting spinal cord astrocytes to motor neurons and polarizing them toward neuroprotective A2 phenotype, and (2) activating regenerative signaling pathways in DRG SGCs.Materials & Methods: C57BL/6J mice underwent SNI followed by intrathecal injection of AAV‐GFAP‐CasRx‐Ptbp1 (targeting Ptbp1 in astrocytes/SGCs) or control virus. Primary astrocytes and SGCs were transfected with Ptbp1 siRNA in vitro. Assessments included functional recovery (Basso Mouse Scale, Louisville Swim Score, Hargreaves test, von Frey assay), axonal regeneration (HE/β3‐tubulin/SCG‐10 staining), transcriptome/ATAC sequencing, and molecular analyses (immunofluorescence for DCX/Islet1/ntng2‐NGL‐2; Western blot for Ptbp1/GDNF/C3).Results: Ptbp1 was upregulated in spinal cord astrocytes and DRG SGCs post‐SNI. Its knockdown accelerated motor/sensory functional recovery and axonal regeneration. Mechanistically, in the spinal cord, Ptbp1 depletion induced astrocyte‐to‐motor neuron conversion (upregulation of DCX/Islet1/Map2) and polarized astrocytes toward A2 phenotype (upregulation of S100a10/GDNF; downregulation of C3). In DRG, it activated the ntng2/NGL‐2 pathway in SGCs, enhancing sensory axon regeneration (upregulation of ATF3/GAP43). Ntng2 blockade abolished sensory regeneration, confirming pathway dependence.Discussion: Ptbp1 knockdown promotes PNI repair through spatially distinct mechanisms: spinal cord astrocyte reprogramming/A2 polarization synergizes with DRG SGC‐mediated ntng2/NGL‐2 activation. While astrocyte‐to‐neuron conversion was limited, dominant A2 polarization provided neuroprotection. The absence of SGC transdifferentiation highlights cell‐type‐specific responses. Limitations include low conversion efficiency and interspecies regenerative differences.Conclusion: Targeting Ptbp1 in glial cells accelerates PNI recovery by dual regenerative mechanisms: motor function restoration via astrocyte‐derived neuron replenishment and A2 polarization, coupled with sensory repair through ntng2/NGL‐2 pathway activation. This establishes Ptbp1 as a promising therapeutic target for nerve injuries.

Knockdown of Ptbp1 in spinal cord astrocytes promotes motor function recovery after sciatic nerve injury by inducing their transdifferentiation into motor neurons and polarization toward the neuroprotective A2 phenotype. Concurrently, Ptbp1 depletion in dorsal root ganglion satellite glial cells enhances sensory axon regeneration through the activation of the ntng2/NGL‐2 signaling pathway.

## Linked entities

- **Genes:** PTBP1 (polypyrimidine tract binding protein 1) [NCBI Gene 5725], DCX (doublecortin) [NCBI Gene 1641], ISL1 (ISL LIM homeobox 1) [NCBI Gene 3670], MAP2 (microtubule associated protein 2) [NCBI Gene 4133], S100A10 (S100 calcium binding protein A10) [NCBI Gene 6281], GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668], C3 (complement C3) [NCBI Gene 718], ATF3 (activating transcription factor 3) [NCBI Gene 467], GAP43 (growth associated protein 43) [NCBI Gene 2596], NTNG2 (netrin G2) [NCBI Gene 84628], LRRC4 (leucine rich repeat containing 4) [NCBI Gene 64101]

## Full-text entities

- **Genes:** Gdnf (glial cell line derived neurotrophic factor) [NCBI Gene 14573] {aka ATF}, Stmn2 (stathmin-like 2) [NCBI Gene 20257] {aka SCG10, Scgn10, Stmb2}, S100a10 (S100 calcium binding protein A10 (calpactin)) [NCBI Gene 20194] {aka 42C, CAL12, CLP11, Cal1l, p10, p11}, Lrrc4 (leucine rich repeat containing 4) [NCBI Gene 192198] {aka MBAG1, NGL-2, NGL2, NLG-2, Nag14}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, Ptbp1 (polypyrimidine tract binding protein 1) [NCBI Gene 19205] {aka HNRPI, PTB-1, PTB2, PTB3, PTB4, Ptb}, Xcl1 (chemokine (C motif) ligand 1) [NCBI Gene 16963] {aka ATAC, LTN, Lptn, SCM-1, SCM-1a, Scyc1}, Dcx (doublecortin) [NCBI Gene 13193] {aka Dbct}, Gap43 (growth associated protein 43) [NCBI Gene 14432] {aka B-50, Basp2, GAP-43}, Ntng2 (netrin G2) [NCBI Gene 171171] {aka 2610016D08Rik, Lmnt2}, Atf3 (activating transcription factor 3) [NCBI Gene 11910] {aka LRG-21}, Isl1 (ISL1 transcription factor, LIM/homeodomain) [NCBI Gene 16392]
- **Diseases:** PNI (MESH:D059348), nerve injuries (MESH:D000080902), SNI (MESH:D020426), sensory and motor deficits (MESH:D001289)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797)

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12287381/full.md

---
Source: https://tomesphere.com/paper/PMC12287381